Literature DB >> 23359628

Cancer incidence and mortality in china, 2007.

Wan-Qing Chen1, Hong-Mei Zeng, Rong-Shou Zheng, Si-Wei Zhang, Jie He.   

Abstract

OBJECTIVE: Cancer incidence and mortality data collected from population-based cancer registries were analyzed to present the overall cancer statistics in Chinese registration areas by age, sex and geographic area in 2007.
METHODS: In 2010, 48 cancer registries reported cancer incidence and mortality data of 2007 to National Central Cancer Registry of China. Of them, 38 registries' data met the national criteria. Incidence and mortality were calculated by cancer sites, age, gender, and area. Age-standardized rates were described by China and World population.
RESULTS: The crude incidence rate for all cancers was 276.16/100,000 (305.22/100,000 for male and 246.46/100,000 for female; 284.71/100,000 in urban and 251.07/100,000 in rural). Age-standardized incidence rates by China and World population were 145.39/100,000 and 189.46/100,000 respectively. The crude mortality rate for all cancers was 177.09/100,000 (219.15/100,000 for male and 134.10/100,000 for female; 173.55/100,000 in urban and 187.49/100,000 in rural). Age-standardized mortality rates by China and World population were 86.06/100,000 and 116.46/100,000, respectively. The top 10 most frequently common cancer sites were the lung, stomach, colon and rectum, liver, breast, esophagus, pancreas, bladder, brain and lymphoma, accounting for 76.12% of the total cancer cases. The top 10 causes of cancer death were cancers of the lung, liver, stomach, esophagus, colon and rectum, pancreas, breast, leukemia, brain and lymphoma, accounting for 84.37% of the total cancer deaths.
CONCLUSION: Cancer remains a major disease threatening people's health in China. Prevention and control should be enhanced, especially for the main cancers.

Entities:  

Keywords:  Cancer registry; China; Incidence; Mortality

Year:  2012        PMID: 23359628      PMCID: PMC3555260          DOI: 10.1007/s11670-012-0001-6

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  4 in total

1.  [Strengthening cancer registration system in China].

Authors:  Wan-qing Chen; Ping Zhao; Ke-qin Rao
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2010-05

2.  Declining cancer mortality in the United States.

Authors:  P Cole; B Rodu
Journal:  Cancer       Date:  1996-11-15       Impact factor: 6.860

3.  Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States?

Authors:  D R Shopland; H J Eyre; T F Pechacek
Journal:  J Natl Cancer Inst       Date:  1991-08-21       Impact factor: 13.506

4.  Cancer incidence and mortality in china, 2006.

Authors:  Wan-Qing Chen; Si-Wei Zhang; Xiao-Nong Zou; Ping Zhao
Journal:  Chin J Cancer Res       Date:  2011-03       Impact factor: 5.087

  4 in total
  52 in total

Review 1.  Ambient air pollution and lung disease in China: health effects, study design approaches and future research.

Authors:  Jeffrey H Mandel; Christine Wendt; Charles Lo; Guangbiao Zhou; Marshall Hertz; Gurumurthy Ramachandran
Journal:  Front Med       Date:  2015-06-18       Impact factor: 4.592

2.  Expression of lncRNA-CCAT1, E-cadherin and N-cadherin in colorectal cancer and its clinical significance.

Authors:  Zhenyu Ye; Ming Zhou; Bin Tian; Bin Wu; Juncheng Li
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  [Quality assessment of global guidelines on colorectal cancer screening].

Authors:  L Gao; S Q Yu; J C Yang; J L Ma; S Y Zhan; F Sun
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-06-18

4.  The promoter methylation status and mRNA expression levels of CTCF and SIRT6 in sporadic breast cancer.

Authors:  Da Wang; Changlong Li; Xuemei Zhang
Journal:  DNA Cell Biol       Date:  2014-05-19       Impact factor: 3.311

5.  Promoter hypermethylation may be an important mechanism of the transcriptional inactivation of ARRDC3, GATA5, and ELP3 in invasive ductal breast carcinoma.

Authors:  Da Wang; Peng-Na Yang; Jin Chen; Xian-Yao Zhou; Qiu-Jun Liu; Hong-Jiang Li; Chang-Long Li
Journal:  Mol Cell Biochem       Date:  2014-08-23       Impact factor: 3.396

6.  Prognostic and clinical significance of STAT3 and MMP9 in patients with gastric cancer: a meta-analysis of a Chinese cohort.

Authors:  Jing Chen; Xiaoxia Liu; Haiyan Jiao; Liang Peng; Zhenghao Huo; Wenjun Yang; Qin Shen; Tao Li; Qilun Liu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

7.  Association of PSMA4 polymorphisms with lung cancer susceptibility and response to cisplatin-based chemotherapy in a Chinese Han population.

Authors:  T Wang; T Chen; A Thakur; Y Liang; L Gao; S Zhang; Y Tian; T Jin; J J Liu; M Chen
Journal:  Clin Transl Oncol       Date:  2015-03-06       Impact factor: 3.405

8.  Characterization of the attenuation of breast cancer bone metastasis in mice by zoledronic acid using (99m)Tc bone scintigraphy.

Authors:  Chunyu Wu; Shunfang Yang; Zhenping Sun; Xianghui Han; Yiyi Ye; Sheng Liu
Journal:  Pathol Oncol Res       Date:  2014-03-08       Impact factor: 3.201

Review 9.  Virus-Derived Peptides for Clinical Applications.

Authors:  Mingying Yang; Kegan Sunderland; Chuanbin Mao
Journal:  Chem Rev       Date:  2017-07-19       Impact factor: 60.622

10.  Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.

Authors:  Peng Tang; Hua Huang; Jiang Chang; Gong-Fang Zhao; Ming-Liang Lu; Yan Wang
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.